Go Pro

Cabot (NYSE:CBT) CEO Sells $237,604.50 in Stock

Cabot logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Cabot CEO Sean Keohane sold 2,779 shares at an average price of $85.50, generating $237,604.50. His remaining stake is valued at approximately $24.7 million.
  • Cabot reported quarterly EPS of $1.67, slightly exceeding analyst expectations, while revenue rose 6.4% year over year to $982 million. The company provided fiscal 2026 EPS guidance of $6.15–$6.45.
  • The company declared a quarterly dividend of $0.4725 per share, equivalent to an annualized $1.89 payout and a 2.2% yield. Analysts maintain a consensus “Hold” rating with an average price target of $89.
  • Interested in Cabot? Here are five stocks we like better.

Cabot Corporation (NYSE:CBT - Get Free Report) CEO Sean Keohane sold 2,779 shares of Cabot stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $85.50, for a total transaction of $237,604.50. Following the sale, the chief executive officer owned 288,873 shares in the company, valued at approximately $24,698,641.50. This represents a 0.95% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Cabot Price Performance

Shares of Cabot stock traded up $0.75 on Wednesday, hitting $84.39. The company had a trading volume of 110,808 shares, compared to its average volume of 472,356. The company has a market cap of $4.36 billion, a PE ratio of 23.77, a PEG ratio of 10.89 and a beta of 0.84. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. Cabot Corporation has a 52 week low of $58.33 and a 52 week high of $94.53. The business has a 50-day simple moving average of $87.99 and a 200-day simple moving average of $81.05.

Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The firm had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. During the same period last year, the company posted $1.90 EPS. The firm's quarterly revenue was up 6.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Research analysts expect that Cabot Corporation will post 6.37 EPS for the current fiscal year.

Cabot Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be given a $0.4725 dividend. The ex-dividend date is Friday, August 28th. This represents a $1.89 annualized dividend and a yield of 2.2%. Cabot's payout ratio is 53.24%.

Wall Street Analyst Weigh In

CBT has been the subject of several research reports. Wall Street Zen raised Cabot from a "hold" rating to a "buy" rating in a research note on Sunday, August 9th. Truist Financial set a $100.00 target price on shares of Cabot in a report on Wednesday, August 5th. Mizuho lifted their price target on Cabot from $80.00 to $90.00 and gave the company a "neutral" rating in a report on Thursday, June 25th. UBS Group dropped their price objective on shares of Cabot from $97.00 to $92.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 5th. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Cabot in a research note on Friday. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $89.00.

View Our Latest Research Report on CBT

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in CBT. BlackRock Inc. bought a new position in Cabot during the second quarter worth $633,302,000. California State Teachers Retirement System grew its stake in shares of Cabot by 8,726.7% in the 2nd quarter. California State Teachers Retirement System now owns 5,593,422 shares of the specialty chemicals company's stock valued at $507,995,000 after purchasing an additional 5,530,053 shares during the period. Bank of America Corp DE bought a new stake in Cabot in the second quarter valued at $150,772,000. Norges Bank bought a new stake in Cabot in the fourth quarter valued at $49,662,000. Finally, Bank of New York Mellon Corp acquired a new position in Cabot during the second quarter worth $57,445,000. 93.18% of the stock is owned by institutional investors.

About Cabot

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Cabot Right Now?

Before you consider Cabot, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.

While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines